Oncology
Kerry Reynolds, MD
Assistant Professor of Medicine, Harvard Medical School; Clinical Director, Inpatient Oncology, Massachusetts General Hospital; Director, Severe Immunotherapy Complications Service, Mass General Brigham
Dr. Kerry L. Reynolds, MD, is a medical oncologist specializing in the management of cancer patients, with a particular focus on immune-related adverse events from immunotherapy. She founded and directs the Severe Immunotherapy Complications Service at Massachusetts General Hospital (Mass General Brigham), the only program of its kind in the country dedicated to addressing severe side effects of immunotherapy, which can impact any organ system including gastrointestinal, pulmonary, cardiac, derm
18+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Massachusetts General Hospital
- Massachusetts General Hospital, Boston, MA
Languages
English
Experience
18+ years in practice